RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEW07E320C1115446BB

https://w3id.org/ripe/ripe-kg/work/RIPEW07E320C1115446BB
SubjectPredicateObject
ripekg:work/10.1097%2Fj.pain.0000000000003503Human cold pain: a randomized crossover trial http://purl.org/spar/cito/cites ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults
ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults dcterms:title A phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults
ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults rdf:type node1
ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults rdf:type rdfs:Resource
ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults rdf:type owl:Thing
ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults rdf:type prov:Entity
ripekg:work/RIPEW07E320C1115446BBA phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults rdf:type ripe:WorkWork